The study advanced beyond a one-size-fits-all model by developing both a global XGBoost classifier and cancer-type-specific ...

The clinical trial failure dilemma. What constitutes clinical trial failure is a matter of perspective. For sponsors, the ...

Artificial intelligence models have immense potential for diagnosing myopia, assessing its risk factors, and predicting its ...

Myopia, or nearsightedness, affects two billion people worldwide. Uncorrected myopia can impair vision, disrupting education, ...

AI advancements in myopia detection and prediction are explored, emphasizing the need for high-quality data and addressing clinical application challenges.